CRVO

Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Total revenue 2.16 M1.92 M1.76 M322.57 K8 726 4.01 M Gross profit 2.16 M1.92 M1.76 M322.57 K8 726 4.01 M Operating expenses 9.4 M7.22 M8.37 M8.37 M8.34 M 32.3 M Selling/general/admin expenses 2.32 M2.38 M3.27 M2.33 M2.51 M 10.48 M Research & development 7.09 M4.84 M5.11 M6.04 M5.83 M 21.82 M Operating income -7.24 M-5.3 M-6.62 M-8.04 M-8.33 M -28.29 M Non-Operating Income, Total 534.91 K408.85 K357.87 K317.56 K244.23 K 1.33 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 532.18 K408.99 K368.13 K318.79 K240.94 K 1.34 M Unusual income/expense 2 726-135-10.26 K-1 2273 291 -8 327 Pretax income -6.71 M-4.89 M-6.26 M-7.73 M-8.09 M -26.97 M Equity in earnings ————— — Taxes ————11.34 M — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -6.71 M-4.89 M-6.26 M-7.73 M-8.09 M -26.97 M Discontinued operations ————— — Net income -6.71 M-4.89 M-6.26 M-7.73 M-8.09 M -26.97 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -6.71 M-4.89 M-6.26 M-7.73 M-8.09 M -26.97 M Basic earnings per share (Basic EPS) -0.79-0.56-0.7-0.84-0.88 -2.98 Diluted earnings per share (Diluted EPS) -0.83-0.56-0.7-0.84-0.89 -2.99 Average basic shares outstanding 8.07 M8.7 M8.95 M9.25 M9.04 M 35.95 M Diluted shares outstanding 8.07 M8.7 M8.95 M9.25 M9.04 M 35.95 M EBITDA ————— — EBIT -7.24 M-5.3 M-6.62 M-8.04 M-8.33 M -28.29 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) ————— —